Sanford Health
Fargo, North Dakota, 58102, United States
NCT Number: NCT05357443
Evaluation of serum gastrin levels and their effect on marginal ulcer formation.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Fargo, North Dakota, 58102, United States
Prospective, randomized, interventional trial. Participants will be randomized to one of two surgical techniques, either with transection of the vagal nerves, or without. Outcomes including compare marginal ulcer rates will be compared using serum gastrin levels before and after surgery and gastric pH during surgery.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vagal nerve interruption above the level of the stomach is a known treatment for complicated peptic ulcer disease. It is not commonly performed during routine gastric bypass. The vagi are, however, interrupted part-way down the stomach to create the gastric pouch. This is the pars flaccida technique.
Dissection between the neurovascular bundle and the stomach, spareing the vagus nerves. This is the perigastric technique.
Time frame: From surgical intervention to five years after surgery
Number of participants with a change in serum gastrin levels compared pre- and post-surgery.
Sanford Health
Other
Effect of Vagus Nerve Preservation During Gastric Bypass on Gastrin Level and Marginal Ulcer Formation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04832282
Gastric Bypass, Weight Regain
Boston, Massachusetts, United States
View Trial DetailsNCT02819037
Bacterial Overgrowth Syndrome, Blind Loop Syndrome
Arras, France
View Trial DetailsNCT05640947
Digestive System Diseases, Fatty Liver
Bruges, Belgium
View Trial DetailsNCT02823665
Gastric Bypass, Glucose Metabolism Disorders
San Antonio, Texas, United States
View Trial Details